[go: up one dir, main page]

HK1069311B - 在多发性骨髓瘤之治疗中作为ikb抑制剂之咔啉衍生物 - Google Patents

在多发性骨髓瘤之治疗中作为ikb抑制剂之咔啉衍生物 Download PDF

Info

Publication number
HK1069311B
HK1069311B HK05101152.7A HK05101152A HK1069311B HK 1069311 B HK1069311 B HK 1069311B HK 05101152 A HK05101152 A HK 05101152A HK 1069311 B HK1069311 B HK 1069311B
Authority
HK
Hong Kong
Prior art keywords
alkyl
phenyl
mono
unsubstituted
group
Prior art date
Application number
HK05101152.7A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1069311A1 (zh
Inventor
Julian Adams
Kenneth C Anderson
Original Assignee
Millennium Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals, Inc. filed Critical Millennium Pharmaceuticals, Inc.
Priority claimed from PCT/US2002/035645 external-priority patent/WO2003039545A2/en
Publication of HK1069311A1 publication Critical patent/HK1069311A1/zh
Publication of HK1069311B publication Critical patent/HK1069311B/zh

Links

HK05101152.7A 2001-11-07 2002-11-06 在多发性骨髓瘤之治疗中作为ikb抑制剂之咔啉衍生物 HK1069311B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34491101P 2001-11-07 2001-11-07
US60/344,911 2001-11-07
PCT/US2002/035645 WO2003039545A2 (en) 2001-11-07 2002-11-06 Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma and others cancers

Publications (2)

Publication Number Publication Date
HK1069311A1 HK1069311A1 (zh) 2005-05-20
HK1069311B true HK1069311B (zh) 2007-10-26

Family

ID=

Similar Documents

Publication Publication Date Title
EP1443927B1 (en) Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma
EP2475659B1 (en) 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
KR101912475B1 (ko) Ｄｎａ-ｐｋ 저해제로서의 이미다조［4,5-ｃ］퀴놀린
EP3268362B1 (en) Substituted pyridines and uses thereof
KR20240089358A (ko) Sos1 억제제와 kras g12d 억제제의 병용 요법
CA3141826A1 (en) Tead inhibitors and uses thereof
AU2013202973B2 (en) Heterocyclic compounds and methods for their use
EP3215150B1 (en) Inhibitors of myocardin-related transcription factor and serum response factor (mrtf/srf)-mediated gene transcription and methods for use of the same
US8435976B2 (en) 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
KR101921764B1 (ko) 피라졸로-퀴놀린
MX2012010557A (es) Morfolinilquinazolinas.
CN109152781A (zh) 作为myd88突变疾病中的治疗靶标的hck
BR122021005850B1 (pt) Compostos, composições moduladoras da interação sestrina-gator2 e usos destes
KR20140097391A (ko) 암 치료에서 사용되기 위한 모르폴리닐 벤조트리아진
WO2015003223A1 (en) Heterocyclic compounds and methods of their use
WO2022261220A1 (en) Proteolysis targeting chimeras and methods of use thereof
CA3237015A1 (en) Heterobifunctional compounds as hpk1 degraders
WO2022266491A1 (en) Proteolysis targeting chimeras and polypharmacological agents targeting bcl-2, and methods of use thereof
HK1069311B (zh) 在多发性骨髓瘤之治疗中作为ikb抑制剂之咔啉衍生物
KR20140144215A (ko) 오로라 키나제 저해제를 사용하는 암 치료 방법
WO2014150252A1 (en) Methods of treatment associated with the granulocyte colony-stimulating factor receptor
EP2163245A1 (en) Renin inhibitors for the treatment of psoriasis
CA2957566A1 (en) Indoline sulfonamide inhibitors of dape and ndm-1 and use of the same
HK1184154B (zh) 作为dna-pk抑制剂的咪唑并[4，5-c]喹啉类化合物